Pathstone Holdings’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,487
Closed -$212K 2280
2025
Q4
$212K Sell
1,487
-808
-35% -$108K ﹤0.01% 2086
2025
Q3
$275K Buy
+2,295
New +$291K ﹤0.01% 2062
2025
Q1
Sell
-2,553
Closed -$396K 2318
2024
Q4
$396K Sell
2,553
-3,489
-58% -$590K ﹤0.01% 1828
2024
Q3
$1.1M Sell
6,042
-64
-1% -$9.48K ﹤0.01% 1317
2024
Q2
$725K Sell
6,106
-1,206
-16% -$127K ﹤0.01% 1495
2024
Q1
$785K Buy
7,312
+1,248
+21% +$124K ﹤0.01% 1444
2023
Q4
$605K Buy
+6,064
New +$593K ﹤0.01% 1383

Other funds holding ICUI

Pathstone Holdings's ICUI Position: Q1 2026 in Review

Pathstone Holdings sold out of ICU Medical (ICUI) in Q1 2026, closing a stake of 1,487 shares — an estimated $212K sold.

Pathstone Holdings first reported a position in ICUI in Q4 2023 and held it in 7 quarters. The position peaked at $1.1M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Pathstone Holdings reported no remaining ICU Medical position as of Q1 2026 after selling out during the quarter.
  • Pathstone Holdings sold 1,487 ICU Medical shares in Q1 2026, an estimated $212K.
  • Pathstone Holdings first reported a position in ICU Medical in Q4 2023 and held it in 7 quarters.
  • Pathstone Holdings's ICU Medical position peaked at $1.1M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.